Viruses · 2024 · 10 citations · 53 references
Life SciencesInfectious DiseasesMolecular BiologyInnate ImmunityMolecular VirologyVirologyAntiviral ImmunityInnate Immune ActivationInnate Immune ResponseInterferon ResponsesViral InfectionsViral PathogenesisAntiviral Signaling PathwaysInnate Immune Recognition Of VirusesMiddle East Respiratory Syndrome CoronavirusMitochondrial Antiviral SignalingProteolytic Cleavage Of Viral PolyproteinsViral Evasion MechanismsViral ProteasesViral Rna Sensing
Mitochondrial antiviral signaling protein (MAVS) is a crucial signaling adaptor in the sensing of positive-sense RNA viruses and the subsequent induction of the innate immune response. Coronaviruses have evolved multiple mechanisms to evade this response, amongst others, through their main protease (Mpro), which is responsible for the proteolytic cleavage of the largest part of the viral replicase polyproteins pp1a and pp1ab. Additionally, it can cleave cellular substrates, such as innate immune signaling factors, to dampen the immune response. Here, we show that MAVS is cleaved in cells infected with Middle East respiratory syndrome coronavirus (MERS-CoV), but not in cells infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This cleavage was independent of cellular negative feedback mechanisms that regulate MAVS activation. Furthermore, MERS-CoV Mpro expression induced MAVS cleavage upon overexpression and suppressed the activation of the interferon-β (IFN-β) and nuclear factor-κB (NF-κB) response. We conclude that we have uncovered a novel mechanism by which MERS-CoV downregulates the innate immune response, which is not observed among other highly pathogenic coronaviruses.
53
Xiao-Dong Li, Lijun Sun, Rashu B. Seth et al. · Proceedings of the National Academy of Sciences · 2005 · 831 citations · Full text
Eric J. Snijder, Yvonne van der Meer, Jessika C. Zevenhoven-Dobbe et al. · Journal of Virology · 2006 · 527 citations · Full text
Middle East Respiratory Syndrome
Yaseen M. Arabi, Hanan H. Balkhy, Frederick G. Hayden et al. · New England Journal of Medicine · 2017 · 511 citations · Full text
SARS-CoV-2 Mpro inhibitors and activity-based probes for patient-sample imaging
Wioletta Rut, Katarzyna Groborz, Linlin Zhang et al. · Nature Chemical Biology · 2020 · 328 citations · Full text